DISTRIBUTION OF PSA-NCAM IN NORMAL, ALZHEIMER'S AND PARKINSON'S DISEASE HUMAN BRAIN

被引:42
|
作者
Murray, Helen C. [1 ,2 ]
Low, Victoria F. [1 ,2 ,4 ]
Swanson, Molly E. V. [1 ,2 ]
Dieriks, Birger V. [1 ,2 ]
Turner, Clinton [3 ]
Faull, Richard L. M. [1 ,2 ]
Curtis, Maurice A. [1 ,2 ]
机构
[1] Univ Auckland, Fac Med & Hlth Sci, Dept Anat & Med Imaging, Private Bag 92019, Auckland 1, New Zealand
[2] Univ Auckland, Fac Med & Hlth Sci, Ctr Brain Res, Private Bag 92019, Auckland 1, New Zealand
[3] Auckland City Hosp, LabPlus, Dept Anat Pathol, Auckland, New Zealand
[4] Max Planck Res Unit Neurogenet, Frankfurt, Germany
关键词
polysialic acid; neural cell adhesion molecule; plasticity; Alzheimer's disease; tau; Parkinson's disease; CELL-ADHESION MOLECULE; HIGHLY POLYSIALYLATED NCAM; NEWLY GENERATED NEURONS; STRUCTURAL PLASTICITY; GABAERGIC INTERNEURONS; SUBSTANTIA-NIGRA; PROGENITOR CELLS; NERVOUS-SYSTEM; DENTATE GYRUS; ADULT-RAT;
D O I
10.1016/j.neuroscience.2016.06.003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Polysialated neural cell adhesion molecule (PSA-NCAM) is a membrane bound glycoprotein widely expressed during nervous system development. While commonly described in the neurogenic niches of the adult human brain, there is limited evidence of its distribution in other brain regions. PSA-NCAM is an important regulator of cell-cell interactions and facilitates cell migration and plasticity. Recent evidence suggests these functions may be altered in neurodegenerative diseases such as Alzheimer's (AD) and Parkinson's disease (PD). This study provides a detailed description of the PSA-NCAM distribution throughout the human brain and quantitatively compares the staining load in cortical regions and sub-cortical structures between the control, AD and PD brain. Our results provide evidence of widespread, yet specific, PSA-NCAM expression throughout the human brain including regions devoid of PSA-NCAM in the rodent brain such as the caudate nucleus (CN) and cerebellum (CB). We also detected a significant reduction in PSA-NCAM load in the entorhinal cortex (EC) of cases that was inversely correlated with hyperphosphorylated tau load. These results demonstrate that PSA-NCAM-mediated structural plasticity may not be limited to neurogenic niches and is conserved in the aged brain. We also provide evidence that PSA-NCAM is reduced in the EC, a region severely affected by AD pathology. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:359 / 375
页数:17
相关论文
共 50 条
  • [41] Nanomedicine against Alzheimer's and Parkinson's Disease
    Tandon, Ankit
    Singh, Sangh J.
    Chaturvedi, Rajnish K.
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (12) : 1507 - 1545
  • [42] Comparison of proline endopeptidase activity in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease
    Mantle, D
    Falkous, G
    Ishiura, S
    Blanchard, PJ
    Perry, EK
    CLINICA CHIMICA ACTA, 1996, 249 (1-2) : 129 - 139
  • [43] Pattern of brain destruction in Parkinson's and Alzheimer's diseases
    Braak, H
    Braak, E
    Yilmazer, D
    deVos, RAI
    Jansen, ENH
    Bohl, J
    JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (04) : 455 - 490
  • [44] Genetic networks in Parkinson's and Alzheimer's disease
    Kelly, Jack
    Moyeed, Rana
    Carroll, Camille
    Luo, Shouqing
    Li, Xinzhong
    AGING-US, 2020, 12 (06): : 5221 - 5243
  • [45] Distribution of VGF peptides in the human cortex and their selective changes in Parkinson's and Alzheimer's diseases
    Cocco, Cristina
    D'Amato, Filomena
    Noli, Barbara
    Ledda, Antonella
    Brancia, Carla
    Bongioanni, Paolo
    Ferri, Gian-Luca
    JOURNAL OF ANATOMY, 2010, 217 (06) : 683 - 693
  • [46] Sialometabolism in Brain Health and Alzheimer's Disease
    Rawal, Punam
    Zhao, Liqin
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [47] Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics
    Pan, Yijun
    Nicolazzo, Joseph A.
    ADVANCED DRUG DELIVERY REVIEWS, 2018, 135 : 62 - 74
  • [48] Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study
    Brosseron, Frederic
    Kolbe, Carl-Christian
    Santarelli, Francesco
    Carvalho, Stephanie
    Antonell, Anna
    Castro-Gomez, Sergio
    Tacik, Pawel
    Namasivayam, Aishwarya Alex
    Mangone, Graziella
    Schneider, Reinhard
    Latz, Eicke
    Wuellner, Ullrich
    Svenningsson, Per
    Sanchez-Valle, Raquel
    Luis Molinuevo, Jose
    Corvol, Jean-Christophe
    Heneka, Michael T.
    ALZHEIMERS & DEMENTIA, 2020, 16 (02) : 292 - 304
  • [49] Expression and Distribution of Carboxypeptidase B in the Hippocampal Subregions of Normal and Alzheimer’s Disease Brain
    Henrietta Papp
    I. Török
    A. Matsumoto
    T. Enomoto
    S. Matsuyama
    P. Kása
    Acta Biologica Hungarica, 2003, 54 : 55 - 62
  • [50] MicroRNAs in the pathophysiology of Alzheimer’s disease and Parkinson's disease: an overview
    Mohammad Rafi Khezri
    Keyvan Yousefi
    Naime Majidi Zolbanin
    Morteza Ghasemnejad-Berenji
    Molecular Neurobiology, 2022, 59 : 1589 - 1603